ESR1 and breast carcinoma: We suggest that the hormonal milieu at the beginning of the menopausal transition with the combination of high levels of Adiol in a woman with normal levels of estrogen promotes the proliferation of normal breast epithelial cell and their derivative luminal A breast cancers, leading to the early rise in ER+PR+ breast cancers.